Azithromycin for Preventing Maternal and Neonatal Infections During Labor.

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Maternal and Neonatal SepsisIntrapartum Antibiotics
Interventions
DRUG

oral azithromycin

we will be administering single-dose oral azithromycin to ladies who go into labor and have no risk factors for sepsis, as there is increased risk of postpartum sepsis in both mother and neonate after normal vaginal delivery in low-income and middle-income countries

OTHER

no azithromycin

participants in this arm will be given only standard labor care and no oral azithromycin

All Listed Sponsors
lead

Armed Forces Hospital, Pakistan

OTHER